Wesley Hsu to Chordoma
This is a "connection" page, showing publications Wesley Hsu has written about Chordoma.
Connection Strength
2.031
-
Hu Y, Singh R, Deng Z, Mintz A, Hsu W. Liposome-Protamine-DNA Nanoparticle-Mediated Delivery of Short Hairpin RNA Targeting Brachyury Inhibits Chordoma Cell Growth. J Biomed Nanotechnol. 2016 Oct; 12(10):1952-61.
Score: 0.583
-
Hu Y, Mintz A, Shah SR, Quinones-Hinojosa A, Hsu W. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival. Carcinogenesis. 2014 Jul; 35(7):1491-9.
Score: 0.484
-
Hsu W, Mohyeldin A, Shah SR, ap Rhys CM, Johnson LF, Sedora-Roman NI, Kosztowski TA, Awad OA, McCarthy EF, Loeb DM, Wolinsky JP, Gokaslan ZL, Quiñones-Hinojosa A. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target. J Neurosurg. 2011 Oct; 115(4):760-9.
Score: 0.404
-
Hsu W, Kosztowski TA, Zaidi HA, Gokaslan ZL, Wolinsky JP. Image-guided, endoscopic, transcervical resection of cervical chordoma. J Neurosurg Spine. 2010 Apr; 12(4):431-5.
Score: 0.371
-
Clarke MJ, Hsu W, Suk I, McCarthy E, Black JH, Sciubba DM, Bydon A, Yassari R, Witham TF, Gokaslan ZL, Wolinsky JP. Three-level en bloc spondylectomy for chordoma. Neurosurgery. 2011 Jun; 68(2 Suppl Operative):325-33; discussion 333.
Score: 0.101
-
Hsu W, Kosztowski TA, Zaidi HA, Dorsi M, Gokaslan ZL, Wolinsky JP. Multidisciplinary management of primary tumors of the vertebral column. Curr Treat Options Oncol. 2009 Apr; 10(1-2):107-25.
Score: 0.088